Progress of powder production technology.
نویسندگان
چکیده
منابع مشابه
Technology for production of surimi powder and potential of applications
Surimi refers to concentrated myofibrial protein extracted from fish flesh by washing process. Surimi powder, is normally prepared in a dried form, and potentially useful as a raw material for preparation of seafood products. Surimi powder offers many advantages in industrial application, such as easy handling, low distribution cost, and physically convenient for addition to dry mixtures. In or...
متن کاملProgress in Titanium Metal Powder Injection Molding
Metal powder injection molding is a shaping technology that has achieved solid scientific underpinnings. It is from this science base that recent progress has occurred in titanium powder injection molding. Much of the progress awaited development of the required particles with specific characteristics of particle size, particle shape, and purity. The production of titanium components by injecti...
متن کاملProduction of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
Bombyx mori (silkworm) silk proteins are being utilized as unique biomaterials for medical applications. Chemical modification or post-conjugation of bioactive ligands expand the applicability of silk proteins; however, the processes are elaborate and costly. In this study, we used transgenic silkworm technology to develop single-chain variable fragment (scFv)-conjugated silk fibroin. The cocoo...
متن کاملProgress in device technology.
Advances in implantable device technology over the past few years can be seen in these illustrations. The photograph on the left shows a 1997-model implantable cardioverter-defibrillator (ICD) in front of an older version. Beside it is a modern single-chamber pacemaker in front of an older mercury-zinc–cell model. The Table shows their relative weights. These devices are now small enough to per...
متن کاملVibration Technology for Active Dry-Powder Inhalers
Timothy M. Crowder, PhD, is chief technology officer at Oriel Therapeutics, Inc., PO Box 14087, Research Triangle Park, NC 27709, tel. 919.313.1290 ext. 11, fax 919.313.1295, [email protected]. ctive dry-powder inhalers (DPIs) for pulmonary drug delivery have been under development for at least 10 years, but to date no such device has been approved by FDA. Like propellant-driven me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: DENKI-SEIKO[ELECTRIC FURNACE STEEL]
سال: 1989
ISSN: 1883-4558,0011-8389
DOI: 10.4262/denkiseiko.60.46